Posted on 8/15/19
Deciphera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced the pricing of its previously . . .
Posted on 8/13/19
Deciphera Pharmaceuticals Announces Proposed Public Offering of Common Stock
WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a clinical-stage biopharmaceutical company focused on addressing key mechanisms of tumor drug resistance, today announced the commencement of a registered . . .
Posted on 8/13/19
Q-State Biosciences and 2bPrecise Announce Partnership
CAMBRIDGE, Mass., CHICAGO & PITTSBURGH--(BUSINESS WIRE)--Q-State Biosciences and 2bPrecise will partner to build robust clinical-genomic datasets enabling healthcare providers to better leverage precision medicine when treating . . .
Posted on 8/13/19
Covetrus Announces Financial Results for Second Quarter of 2019
PORTLAND, Maine , Aug. 13, 2019 (GLOBE NEWSWIRE) -- Covetrus?(Nasdaq: CVET),?a global?leader in?animal-health technology and services, today announced financial results for the second quarter of 2019, . . .
Posted on 8/12/19
CommonCensus Announces Partnership with ConnectYourCare
CommonCensus of Westbrook, ME announces the expansion of our ZeroPEPM portfolio with the addition of ConnectYourCare."ConnectYourCare is an ideal addition to the ZeroPEPM portfolio because almost . . .
Posted on 8/12/19
MariMed Reports Record Q2 2019 Results; Revenue Up 774% to $25.7 Million, Net Income of $4.7 Million
NORWOOD, Mass., Aug. 12, 2019 (GLOBE NEWSWIRE) -- MariMed Inc. (MRMD), a leading multi-state cannabis and hemp operator focused on health and wellness, reported record results . . .
Posted on 8/12/19
Entasis Therapeutics Reports Second Quarter 2019 Financial Results and Provides Business Update
WALTHAM, Mass., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel . . .
Posted on 8/12/19
Better Buy: Vertex Pharmaceuticals vs. Alexion Pharmaceuticals
Alexion Pharmaceuticals (NASDAQ:ALXN) and Vertex Pharmaceuticals (NASDAQ:VRTX) rank as two of the most successful biotechs focused on rare diseases on the planet. The stock performances for . . .
Posted on 8/9/19
Voyager Therapeutics Reports Second Quarter 2019 Financial Results and Corporate Highlights
CAMBRIDGE, Mass., Aug. 09, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological . . .
Posted on 8/9/19
What You'll Want to Know About Corbus Pharmaceuticals' Q2 Results
Corbus Pharmaceuticals(NASDAQ:CRBP) has had some good news so far in 2019. Its sharessoared in Aprilafter Jefferies initiated coverage on the stock with a buy rating and . . .
Posted on 8/8/19
Synlogic Provides Program Updates
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Synlogic, Inc. (NASDAQ:SYBX), a clinical stage company applying synthetic biology to beneficial microbes to develop novel, living medicines, today reported its financial results for . . .
Posted on 8/8/19
CVS Health Corporation Announces Cash Tender Offers for Certain Outstanding Notes
CVS Health Corporation (NYSE: CVS) announced today that it has commenced cash tender offers for (1) any and all of its 3.125% Senior Notes due 2020, . . .
Posted on 8/8/19
Ironwood Pharmaceuticals Announces Pricing of Upsized $350 Million Convertible Senior Notes Offering
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced the pricing of $175 million aggregate principal amount of convertible senior unsecured notes that . . .
Posted on 8/8/19
Selecta Biosciences Reports Second Quarter 2019 Financial Results and Provides Corporate Update
WATERTOWN, Mass., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (NASDAQ: SELB), a clinical-stage biotechnology company focused on unlocking the full potential of biologic therapies . . .
Posted on 8/8/19
Karuna Therapeutics Reports Second Quarter 2019 Financial Results and Provides General Business Update
BOSTON--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (Nasdaq: KRTX), a clinical-stage biopharmaceutical company primarily focused on developing novel therapies to address disabling neuropsychiatric conditions, today announced financial results for . . .
Posted on 8/8/19
Corindus Vascular Robotics to Be Acquired by Siemens Healthineers
Corindus Vascular Robotics (NYSE American: CVRS), a leading developer of precision vascular robotics, today announced that it has entered into a definitive merger agreement
Posted on 8/8/19
bluebird bio Prepares for Launch
bluebird bio's (NASDAQ:BLUE) second-quarter financial report was fairly mundane, with no drugs generating revenue. But that will change shortly, given the recent European approval of Zynteglo . . .
Posted on 8/8/19
What's Behind AMAG Pharmaceuticals' Horrible Q2 Results
AMAG Pharmaceuticals(NASDAQ:AMAG)didn't please investors one bit when the company announced its results in May. Revenue fell 35% while its net loss worsened. Any hopes for better . . .
Posted on 8/8/19
Proteostasis Therapeutics Provides Corporate Update
Proteostasis Therapeutics, Inc. (NASDAQ: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF) and other . . .
Posted on 8/7/19
Ra Pharmaceuticals Reports Second Quarter 2019 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced financial results for the second quarter ended June 30, 2019, and provided an update on recent corporate and . . .
Posted on 8/7/19
ArQule Reports Second Quarter 2019 Financial Results
URLINGTON, Mass.--(BUSINESS WIRE)--ArQule, Inc. (Nasdaq: ARQL) today announced its financial results for the second quarter of 2019.For the quarter ended June 30, 2019, the Company reported . . .
Posted on 8/7/19
Moderna Provides Business Updates and Reports Second Quarter 2019 Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Moderna, Inc. (Nasdaq: MRNA), a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines . . .
Posted on 8/7/19
CVS Health Reports Second Quarter Results
CVS Health Corporation (NYSE: CVS) today announced operating results for the three months ended June 30, 2019.President and Chief Executive Officer Larry Merlo stated, "We posted . . .
Posted on 8/7/19
Celgene Continues Growing While Waiting for its Acquisition to Close
Celgene (NASDAQ:CELG) turned in a solid second quarter, allowing management to raise 2019 guidance as the company waits to be acquired by Bristol-Myers Squibb (NYSE:BMY).The deal . . .
Posted on 8/6/19
Ironwood Pharmaceuticals Proposes Offering of $330M of Convertible Senior Notes
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today announced that it intends to offer, subject to market and other conditions, $165 million . . .

